Classical swine fever virus failed to activate nuclear factor-kappa b signaling pathway both in vitro and in vivo
- Li-Jun Chen†1,
- Xiao-Ying Dong†1,
- Ming-Qiu Zhao1,
- Hai-Yan Shen1,
- Jia-Ying Wang1,
- Jing-Jing Pei1,
- Wen-Jun Liu1,
- Yong-Wen Luo1,
- Chun-Mei Ju1 and
- Jin-Ding Chen1Email author
© Chen et al.; licensee BioMed Central Ltd. 2012
Received: 12 April 2012
Accepted: 15 November 2012
Published: 27 November 2012
Classical swine fever virus (CSFV) is the cause of CSF which is a severe disease of pigs, leading to heavy economic losses in many regions of the world. Nuclear factor-kappa B (NF-κB) is a critical regulator of innate and adaptive immunity, and commonly activated upon viral infection. In our previous study, we found that CSFV could suppress the maturation and modulate the functions of monocyte-derived dendritic cells (Mo-DCs) without activating NF-κB pathway. To further prove the effects of CSFV on the NF-κB signaling pathway, we investigated the activity of NF-κB after CSFV infection in vivo and in vitro.
Attenuated Thiverval strain and virulent wild-type GXW-07 strain were used as challenge viruses in this study. Porcine kidney 15 (PK-15) cells were cultured in vitro and peripheral blood mononuclear cells (PBMCs) were isolated from the blood of CSFV-infected pigs. DNA binding of NF-κB was measured by electrophoretic mobility shift assays (EMSA), NF-κB p65 translocation was detected using immunofluorescent staining, and p65/RelA and IκBα expression was measured by Western Blotting.
Infection of cells with CSFV in vitro and in vivo showed that compared with tumor necrosis factor alpha (TNF-α) stimulated cells, there was no distinct DNA binding band of NF-κB, and no significant translocation of p65/RelA from the cytoplasm to the nucleus was observed, which might have been due to the apparent lack of IkBa degradation.
CSFV infection had no effect on the NF-κB signaling pathway, indicating that CSFV could evade host activation of NF-κB during infection.
KeywordsCSFV NF-κB PK-15 PBMC p65 IκBα
CSFV, together with Bovine viral diarrhoea virus (BVDV) and sheep Border disease virus (BDV), belongs to the genus Pestivirus, the family Flaviviridae. CSFV is known to have high affinity to cells of the immune system, which seems to relate to its detrimental effects on the immune and hematopoietic systems. Furthermore, CSFV can efficiently evade and compromise the host immune system, causing a severe disease of pigs characterized by fever, hemorrhage, thrombocytopenia, lymphoid organ atrophy and severe lymphopenia, particularly in B cells, due to the apoptosis of uninfected lymphocytes[3, 4]. The lymphopenia can result in immunosuppression and serves as a hallmark of CSFV infections. Pestiviruses such as CSFV and BVDV can also cross the placenta to infect the developing fetus, resulting in the birth of persistently infected animals[5, 6]. Recently, studies have found that CSFV evolves mechanisms for the inhibition of inflammation and type I interferon (IFN) production in infected cells, preventing double-stranded RNA-mediated apoptosis and giving rise to long-term infections[7, 8]. Although a large number of works have been done, the mechanism of the CSFV infection in vivo and in vitro has not been fully elucidated.
Viruses have evolved sophisticated control mechanisms to redirect the cellular signal transduction pathway to its own advantage, and NF-κB pathway is a common target of many viruses. The NF-κB pathway is recognized to be the central mediator of immune responses in mammals, because several proteins encoded by target genes of NF-κB participate in the activation of immune and inflammatory responses. Therefore, NF-κB activation during viral infection has been interpreted as a protective response of the host to the viral pathogen. Interestingly, certain viruses can utilize the activation of NF-κB as a strategy to increase viral replication and viral progeny production. Whereas other reports indicate that some viruses inhibit the NF-κB pathway[13–18]. The suppression of NF-κB activation represents a potential strategy of viral escape from the host immune system and contributes to virus pathogenesis in infected cells.
NF-κB is also a host nuclear transcription factor, activated by multiple stimuli including inflammatory cytokines, growth factors, bacterial and viral infections, and plays an important role in inflammation, innate immune responses, regulation of cell proliferation and survival[11, 19, 20]. In non-stimulated cells, NF-κB is sequestered as a cytoplasmic complex, whose predominant form is a heterodimer consisting of p50 and p65 (RelA) subunits, bound to inhibitory IκB proteins[21, 22]. Stimulation of cells by diverse agents causes phosphorylation of IκB and its degradation by the proteosome subsequently. Liberated NF-κB is transported into the nucleus where it induces the transcription of target genes, including IκBα acting as the major feedback inhibitor of the NF-κB pathway.
In the present study, we investigated NF-κB activity in vivo and in vitro in order to elucidate how CSFV carried out its infection in the host. The results demonstrate that CSFV does not activate the NF-κB signaling pathway which may represent a mechanism of CSFV-induced immunomodulation.
DNA binding activity of NF-κB by EMSA analysis
NF-κB p65 translocation in CSF- infected PK-15 cells using immunofluorescent staining
p65/RelA and IκBα expression measured by western blotting
The interactions between virus and host may lead to activation or inhibition of NF-κB pathway, resulting in either antiviral responses or enhanced viral replication and virulence. In this report, we investigated the effects of CSFV infection on NF-κB activity in the host using in vitro and in vivo cell models. Our findings suggest that CSFV infection is incapable of activating NF-κB pathway, as demonstrated by the failure in inducing DNA binding activity of NF-κB, and in causing the translocation of p65/RelA from cytoplasm to the nucleus or the degradation of inhibitor IκBα.
NF-κB plays a crucial role in the process of viral infection. Many viruses activate NF-κB to use it as a transcriptional factor to express viral genes. For example, NF-κB activation appears to be necessary for fully efficient HSV replication and the transcription of viral genes which have NF-κB response elements in their promoters[12, 27, 28]. NF-κB, however, is potentially dangerous to virus. The activation of NF-κB during viral infection has been considered to be a protective response of the host to the viral pathogens[11, 29]. Thus, viruses must subtly control the timing and duration of NF-κB activation to ensure its usefulness as a transcription factor while restricting its antiviral effects. In contrast, some viruses have evolved strategies to block NF-κB activation in order to evade the innate immune response. Human cytomegalovirus encodes a hIL-10 homolog to inhibit the NF-κB transcriptional activity. African swine fever virus encodes an IκBα homolog to inhibit the NF-κB pathway by acting as a dominant-negative IκBα protein; Foot-and-mouth disease virus encodes L protein to disrupt the integrity of NF-κB; Torque teno virus ORF2 protein can suppress NF-κB activity in a dose-dependent manner and Varicella-zoster virus can inhibit the NF-κB pathway by sequestering p50 and p65 in the cytoplasm of infected cells. However, these authors provide no evidence in in vivo model. Our results both in vivo and in vitro show that CSFV has no ability to activate NF-κB, revealing the important ability of CSFV to evade the host immune response and to maintain the life cycle of the virus so as to establish persistent infection, which are consistent to the reports of other researchers[5, 6]. Additionally, we find that wild-type or attenuated CSFV strain used in this study shows no difference in activating the NF-κB signaling pathway in PK-15 cells and PBMCs, indicating CSFV with different virulence exerts its influence on NF-κB activity in the same way after it infects the cells.
Viral infection blocks NF-κB activity through various mechanisms. Our study in vitro and in vivo further demonstrates that the potential mechanism of inability of NF-κB directly depends on the stabilization of IκBα levels. IκBα binds to nuclear localization signal motifs in p50 and p65 to inhibit their nuclear translocation, and the stabilization of IκBα in CSFV-infected cells accounts for the cytoplasmic sequestration of p65/RelA. In most cases, inhibitor IκB irreversibly binds to viral proteins or interferes with IκB degradation, resulting in the inhibition of p65/RelA nuclear translocation. Interestingly, a recent research has described that the Npro product of CSFV had the ability to interact with IκBα and exhibited transient accumulation of pIκBα. Similarly, Gil et al. (2006) reported that the infection of non-cytopathic BVDV (ncp BVDV) together with CSFV could block NF-κB activation. Npro of BVDV was also involved in NF-κB inhibition, but the Npro activity was not essential for NF-κB inhibition. The detailed molecular mechanisms and viral components underlying the suppression of NF-κB activation remain to be elucidated. The ability of CSFV to avoid activating NF-κB to optimize its replication or to control host cell proliferation and survival, the understanding of the molecular mechanisms utilized by the pathogen to interfere with the NF-kB pathway, may enable us to exploit NF-κB as a new weapon against viral diseases. Similar result was described by Santoro et al. (2003).
In conclusion, we identify that CSFV infection cannot activate the NF-κB signaling pathway in vitro and in vivo. This mechanism might be utilized by the virus to escape immune rejection and allow the spread of infection. Therefore, understanding the role of NF-κB following CSFV infection would contribute important information about the molecular pathogenesis of CSFV infection.
CSFV GXW-07 strain (wild-type strain) and attenuated Thiverval strain were used in this study. The virulent wild-type CSFV GXW-07 strain was originally isolated from a lymphoid tissue sample of a pig with naturally occurring CSF and propagated in PK-15 cells, and its sequence had been analyzed and submitted to GeneBank (No. HQ380231.1). Attenuated Thiverval strain was obtained from the virulent CSFV Alfort strain which was sub-cultured at 29-30°C in PK-15 cells for 170 generations. Virus titres were determined and calculated as described previously.
PK-15 cells used for viral infection were preserved and propagated in our laboratory (Laboratory of Microbiology and Immunology, College of Veterinary, South China Agricultural University). The cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal calf serum (FCS), 100 U of penicillin/mL and 100 U of streptomycin/ml at 37°C in a humidified 5% CO2 incubator and seeded one day prior to viral infection. Then PK-15 cell monolayer was mock treated, or infected with either CSFV Thiverval strain or GXW-07 strain at multiplicity of infection (MOI) of 1. As a positive control, PK-15 cells were treated with 10 ng/ml TNF-α (R&D Systems).
PBMC isolation after CSFV infection
CSFV RNA and CSFV antibody were measured respectively using RT-PCR and antibody assay kit in 50-day-old Landrace pigs to choose negative pigs. Then three negative pigs in each group were intramuscularly injected with l ml CSFV Thiverval strain or GXW-07 strain (105TCID50/ ml), and pigs intramuscularly injected with l ml physiological saline were used as a negative control. At 1, 4 and 7d p.i., 10 ml blood from each pig was collected in sodium heparin-CPT tubes and diluted with an equal volume of phosphate buffered saline (PBS). Then 5 ml diluent was carefully loaded into tubes containing 5 ml lydroxypropylmethyl cellulose and centrifuged at 1500 rpm for 20 minutes at room temperature. The buffy coat layer was transferred to a 15 ml RNAse-free tube, diluted with an equal volume of PBS, and centrifuged at 1500 rpm for 20 minutes at room temperature. The supernatant was discarded and PBMCs were diluted with 9 ml red cell lysate, and centrifuged at 1000 rpm for 10 minutes at room temperature after ice bath for 2-3 min. The supernatant was discarded and PBMCs were diluted with PBS for three times. PBMCs were retained and used to detect NF-κB activity.
The in vivo experiment was carried out according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by Medical Experimental Animal Center of Guangdong Province (Permit Number: 12-179). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering.
Electrophoretic mobility shift assays (EMSA)
PK-15 cells mock treated, TNF-α (10ng/mL) stimulated, or infected with either Thiverval strain or GXW-07 strain were harvested for 48 h, and nuclear protein extracts were prepared with the nuclear extraction kit (Pierce, USA). The protein concentration of the cell extract was measured by the Bradford assay (Pierce, USA). Activation of p65/IκBα was determined by EMSA (Roche, USA) according to the manufacturer's manual. A DIG-labeled double-stranded oligonucleotide containing a κB binding site (GGGACTTTCC) was used as a probe in the assay. Anti-p65 rabbit polyclonal antibodies (Neomarker, USA) were used in supershift assays. For competition assays, a 100-fold molar excess of unlabeled oligonucleotide was added. DNA binding activity of NF-κB in PBMCs obtained from infected pigs was also determined in the same way mentioned above.
Subcellular localization of p65/IκBα was determined by immunofluorescencent staining. At different time points, cultured PK-15 cells in four treatments were washed with PBS, fixed in 80% acetone for 10 min, and permeabilized for internal staining with PBS containing 0.1% Triton X-100 (Sigma, USA) for 30 min. The cells were then blocked in TBS containing 3% BSA (Sigma, USA) for 30 min and incubated with rabbit polyclonal anti-p65 (diluted 1:100; Neomarker, USA) or anti-IκBα (diluted 1:500; Santa Cruz, USA) antibodies diluted in 1% BSA-TBS at 37°C for 2-3 h. After washed three times with TBS, the cells were further incubated with either QDs-SA 605 (excitation wavelength of ultraviolet light and fluorescent emission 605 nm, red fluorescent) or QDs-SA 545 (excitation wavelength of ultraviolet light and fluorescent emission 545nm, green fluorescent) (Molecular Probes, Jiayuan Quantum Dots, Wuhai, China)-conjugated and biotinylated secondary antibodies at a 1:200 dilution in TBS/1% BSA at 37°C for 30 min. Then cells were stained with DAPI for 10 min and washed twice in TBST and TBS respectively. The coverslips were mounted onto microscope slides, and cells were visualized using a Leica SP2 confocal scanning laser microscope (Leica) with the appropriate barrier filters.
Western blot analysis
Cells were lysed in Cell Lysis Buffer (Cell Signaling, USA) supplemented with 1 mM phenylmethylsulfonyl fluoride (PMSF) for 30min on ice and clarified by centrifugation for total protein extraction. Protein concentration was quantified as described in EMSA. Circa 20 μg of proteins was separated by 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose (NC) membranes. The membranes were blocked in TBST containing 5% powdered milk for 3 h and incubated overnight with primary antibodies at 4°C. Blots were washed and probed with secondary antibody at 37°C for 1 h. The membranes were then developed with enhanced chemiluminescence substrate (Amersham) and exposed to X-ray. As a control, the gels were stripped and re-probed with antibodies against β-actin. Polyclonal anti-NF-κB/p65 (diluted 1:200; Neomarker, USA), polyclonal anti-IκBα (diluted 1:1000; Santa Cruz, USA), polyclonal anti-β-actin (diluted 1:500; Boisynthesia, China) and HRP-conjugated anti-rabbit secondary antibody (diluted 1:1000; Santa Cruz, USA) were used in this study.
LJ Chen and HY Shen have a PhD in Preventive Veterinary Medicine and have been working on cell signaling pathway induced by viral infection; XY Dong and WJ Liu are involved in evaluation of immune responses after vaccination in virus-infected animals; MQ Zhao and YW Luo study transmission of CSFV and vaccine responses after viral infection; JJ Pei and JY Wang carry out the investigation in cell apoptosis and autophagy after viral and bacterial infection; CM Ju has a PhD in Preventive Veterinary Medicine and investigates pig diseases; JD Chen holds a PhD in Preventive Veterinary Medicine and works on immunology and microbiology. He also makes investigation into cell signaling pathway after viral infection.
Border disease virus
Bovine viral diarrhoea virus
Classical swine fever virus
Dulbecco’s modified Eagle’s medium
Electrophoretic mobility shift assays
Fetal calf serum
Type I interferon
Monocyte-derived dendritic cells
Nuclear factor-kappa B
Peripheral blood mononuclear cells
Phosphate buffered saline
Porcine kidney 15
SDS-polyacrylamide gel electrophoresis
Tumor necrosis factor-alpha.
This work was supported by grants from the National Natural Science Foundation of China (Nos. 31072137 and 31172321), the Key Project of Natural Science Foundation of Guangdong Province, China (No.S2011020001037), Special Project for Scientific and Technological Innovation in Higher Education of Guangdong, China (No.2012CXZD0013), Special Fund for Agro-Scientific Research in the Public Interest (No.201203056) and Research Fund for the Doctoral Program of Higher Education of China (No.20114404110015).
- Becher P, Thiel HJ: Genus Pestivirus (Flaviviridae). In The springer index of viruses. Edited by: Tidona CA, Darai G. Heidelberg, Germany: Springer; 2002:327-331.View Article
- Summerfield A, Knoetig SM, McCullough KC: Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J Virol 1998, 72: 1853-1861.PubMedPubMed Central
- Jamin A, Gorin S, Cariolet R, Potier MFL, Kuntz-Simon G: Classical swine fever virus induces activation of plasmacytoid and conventional dendritic cells in tonsil, blood, and spleen of infected pigs. Vet Res 2008, 39: 7. 10.1051/vetres:2007045PubMedView Article
- Sato M, Mikami O, Kobayashi M, Nakajima Y: Apoptosis in the lymphatic organs of piglets inoculated with classical swine fever virus. Vet Microbiol 2000, 75: 1-9. 10.1016/S0378-1135(00)00198-XPubMedView Article
- Charleston B, Fray MD, Baigent S, Carr BV, Morrison WI: Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon. J Gen Virol 2001, 82: 1893-1897.PubMedView Article
- Doceul V, Charleston B, Crooke H, Reid E, Powell PP, Seago J: The Npro product of classical swine fever virus interacts with IκBα, the NF-κB inhibitor. J Gen Virol 2008, 89: 1881-1889. 10.1099/vir.0.83643-0PubMedView Article
- Bensaude E, Turner JLE, Wakeley PR, Sweetman DA, Pardieu C, Drew TW, Wileman T, Powel PP: Classical swine fever virus induces proinflammatory cytokines and tissue factor expression and inhibits apoptosis and interferon synthesis during the establishment of long-term infection of porcine vascular endothelial cells. J Gen Virol 2004, 85: 1029-1037. 10.1099/vir.0.19637-0PubMedView Article
- Ruggli N, Bird BH, Liu L, Bauhofer O, Tratschin JD, Hofmann MA: Npro of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-α/β induction. Virology 2005, 340: 265-276. 10.1016/j.virol.2005.06.033PubMedView Article
- Amici C, Rossi A, Costanzo A, Ciafre S, Marinari B, Balsamo M, Levrero M, Santoro MG: Herpes simplex virus disrupts NF-κB regulation by blocking its recruitment on the IκBα promoter and directing the factor on viral genes. J Bio Chem 2006, 281: 7110-7117. 10.1074/jbc.M512366200View Article
- Pahl HL: Activators and target genes of RelA/NF-κB transcription factors. Oncogene 1999, 18: 6853-6866. 10.1038/sj.onc.1203239PubMedView Article
- Santoro MG, Rossi A, Amici C: NF-kappa B and virus infection: who controls whom. EMBO J 2003, 22: 2552-2560. 10.1093/emboj/cdg267PubMedPubMed CentralView Article
- Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL: Efficient replication by herpes simplex virus type 1 involves activation of the IκB kinase-IκB-p65 pathway. J Virol 2004, 78: 13582-13590. 10.1128/JVI.78.24.13582-13590.2004PubMedPubMed CentralView Article
- Indoh T, Yokota S, Okabayashi T, Yokosawa N, Fujii N: Suppression of NF-κB and AP-1 activation in monocytic cells persistently infected with measles virus. Virol 2007, 361: 294-303. 10.1016/j.virol.2006.11.002View Article
- Jones JO, Arvin AM: Inhibition of the NF-κB pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. J Virol 2006, 80: 5113-5124. 10.1128/JVI.01956-05PubMedPubMed CentralView Article
- Nachtwey J, Spencer JV: HCMV IL-10 Suppresses cytokine expression in monocytes through inhibition of nuclear factor-κB. Viral Immunol 2008, 21: 477-482. 10.1089/vim.2008.0048PubMedPubMed CentralView Article
- Santos T, Segundo FDS, Grubman MJ: Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 2007, 81: 12803-12815. 10.1128/JVI.01467-07PubMed CentralView Article
- Silk RN, Bowick GC, Abrams CC, Dixon LK: African swine fever virus A238L inhibitor of NF-κB and of calcineurin phosphatase is imported actively into the nucleus and exported by a CRM1-mediated pathway. J Gen Virol 2007, 88: 411-419. 10.1099/vir.0.82358-0PubMedView Article
- Zheng H, Ye L, Fang X, Li B, Wang Y, Xiang X, Kong L, Wang W, Zeng Y, Ye L, Wu Z, She Y, Zhou X: Torque teno virus (SANBAN Isolate) ORF2 protein suppresses NF-κB pathways via interaction with IκB kinases. J Virol 2007, 81: 11917-11924. 10.1128/JVI.01101-07PubMedPubMed CentralView Article
- Lin S, Wu M, Xu Y, Xiong W, Yi Z, Zhang X, Zheng HY: Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation. Biochim Biophys Acta 2007, 1772: 1150-1157. 10.1016/j.bbadis.2007.08.001PubMedView Article
- Lin YC, Hsu EC, Ting LP: Repression of hepatitis B viral gene expression by transcription factor nuclear factor-kappaB. Cell Microbiol 2009, 11: 645-660. 10.1111/j.1462-5822.2008.01280.xPubMedView Article
- Moon DO, Kim MO, Kang SH, Choi YH, Kim GY: Sulforaphane suppresses TNF-a-mediated activation of NF-κB and induces apoptosis through activation of reactive oxygen species-dependent caspase-3. Cancer Lett 2009, 274: 132-142. 10.1016/j.canlet.2008.09.013PubMedView Article
- Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, Moore F, Théâtre E, Verhaeghe C, Magnusson NE, Chariot A, Ørntoft TF, Eizirik DL: Induction of nuclear factor-κB and its downstream genes by TNF-α and IL-1β has a pro-apoptotic role in pancreatic beta cells. Diabetologia 2008, 51: 1213-1225. 10.1007/s00125-008-0999-7PubMedView Article
- Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of IκB-alfa proteolysis by site specific signal induced phosphorylation. Science 1995, 267: 1485-1487. 10.1126/science.7878466PubMedView Article
- Atkinson PG, Coope HJ, Rowe M, Ley SC: Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. J Bio Chem 2003, 278: 51134-51142. 10.1074/jbc.M304771200View Article
- Lee SM, Kleiboeker SB: Porcine arterivirus activates the NF-κB pathway through IκB degradation. Virology 2005, 342: 47-59. 10.1016/j.virol.2005.07.034PubMedView Article
- Shisler JL, Jin XL: The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J Virol 2004, 78: 3553-3560. 10.1128/JVI.78.7.3553-3560.2004PubMedPubMed CentralView Article
- Patel A, Hanson J, McLean TI, Olgiate J, Hilton M, Miller WE, Bachenheimer SL: Herpes simplex type 1 induction of persistent NF-kappa B nuclear translocation increases the efficiency of virus replication. Virology 1998, 247: 212-222. 10.1006/viro.1998.9243PubMedView Article
- Taddeo B, Zhang W, Lakeman F, Roizman B: Cells lacking NF-κB or in which NF-κB is not activated vary with respect to ability to sustain herpes simplex virus 1 replication and are not susceptible to apoptosis induced by a replication-incompetent mutant virus. J Virol 2004, 78: 11615-11621. 10.1128/JVI.78.21.11615-11621.2004PubMedPubMed CentralView Article
- Wei L, Kuang J, Wang J, Shi L, Yang B, Li Y, Liu J: Porcine circovirus type 2 induces the activation of nuclear factor kappa B by IκBα degradation. Virology 2008, 378: 177-184. 10.1016/j.virol.2008.05.013PubMedView Article
- Hiscott J, Kwon H, Genin P: Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 2001, 107: 143-151. 10.1172/JCI11918PubMedPubMed CentralView Article
- Richmond A: Nf-kappa B, chemokine gene transcription and tumor growth. Nat Rev Immunol 2002, 2: 664-674. 10.1038/nri887PubMedPubMed CentralView Article
- Gil LHVG, van Olphen AL, Mittal SK, Donis RO: Modulation of PKR activity in cells infected by bovine viral diarrhea virus. Virus Res 2006, 116: 69-77. 10.1016/j.virusres.2005.08.011PubMedView Article
- Knoetig SM, Summerfield A, Spagnuolo-Weaver M, McCullough KC: Immunopathogenesis of classical swine fever: role of monocytic cells. Immunology 1999, 97: 359-366. 10.1046/j.1365-2567.1999.00775.xPubMedPubMed CentralView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.